These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 27712761)

  • 1. Diagnostic Evaluation in Aspirin-Exacerbated Respiratory Disease.
    Williams AN
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):657-668. PubMed ID: 27712761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performing Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease.
    Waldram JD; Simon RA
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):693-703. PubMed ID: 27712764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease.
    Berges-Gimeno MP; Simon RA; Stevenson DD
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):474-8. PubMed ID: 12452205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
    White AA; Stevenson DD; Simon RA
    Ann Allergy Asthma Immunol; 2005 Oct; 95(4):330-5. PubMed ID: 16279562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of LTRA in L-ASA Challenge for Aspirin-Exacerbated Respiratory Disease Diagnosis.
    Ramírez-Jiménez F; Vázquez-Corona A; Sánchez-de la Vega Reynoso P; Pavón-Romero GF; Jiménez-Chobillon MA; Castorena-Maldonado AR; Teran LM
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1554-1561. PubMed ID: 33160093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis.
    Stevens WW; Schleimer RP
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):669-680. PubMed ID: 27712762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs.
    Campo P; Ayuso P; Salas M; Plaza MC; Cornejo-García JA; Doña I; Torres MJ; Blanca-López N; Canto G; Guéant JL; Sanak M; Blanca M
    Allergy; 2013 Aug; 68(8):1001-7. PubMed ID: 23889565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin exacerbated respiratory disease: Current topics and trends.
    Rodríguez-Jiménez JC; Moreno-Paz FJ; Terán LM; Guaní-Guerra E
    Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease.
    Mullol J; Picado C
    Immunol Allergy Clin North Am; 2013 May; 33(2):163-76. PubMed ID: 23639706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Importance of aspirin challenges in patients with NSAID-exacerbated respiratory disease].
    Förster-Ruhrmann U; Olze H
    HNO; 2024 Jul; 72(7):494-498. PubMed ID: 38597968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics of Aspirin-Exacerbated Respiratory Disease.
    Stevenson DD; White AA
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):643-655. PubMed ID: 27712760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history and clinical features of aspirin-exacerbated respiratory disease.
    Fahrenholz JM
    Clin Rev Allergy Immunol; 2003 Apr; 24(2):113-24. PubMed ID: 12668892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on the management of aspirin-exacerbated respiratory disease.
    Lee JH; Jung CG; Park HS
    Expert Rev Respir Med; 2018 Feb; 12(2):137-143. PubMed ID: 29249187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control - A possible oversight link.
    Tan JHY; Hsu AAL
    Respir Med; 2016 Sep; 118():1-3. PubMed ID: 27578463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin-exacerbated respiratory disease: clinical disease and diagnosis.
    Bochenek G; Niżankowska-Mogilnicka E
    Immunol Allergy Clin North Am; 2013 May; 33(2):147-61. PubMed ID: 23639705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin-exacerbated respiratory disease and current treatment modalities.
    Sakalar EG; Muluk NB; Kar M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of Benefit with Aspirin Therapy in Aspirin-Exacerbated Respiratory Disease.
    Hill J; Burnett T; Katial R
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):735-747. PubMed ID: 27712767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation and diagnosis of aspirin-exacerbated respiratory disease.
    Haque R; White AA; Jackson DJ; Hopkins C
    J Allergy Clin Immunol; 2021 Aug; 148(2):283-291. PubMed ID: 34364538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs.
    Simon RA
    Curr Allergy Asthma Rep; 2004 Jan; 4(1):17-24. PubMed ID: 14680616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials.
    Morales DR; Lipworth BJ; Guthrie B; Jackson C; Donnan PT; Santiago VH
    J Allergy Clin Immunol; 2014 Jul; 134(1):40-5. PubMed ID: 24388008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.